Fatty acids (FAs) are known to be important regulators of insulin secretion from pancreatic ␤-cells. FA-coenzyme A esters have been shown to directly stimulate the secretion process, whereas long-term exposure of ␤-cells to FAs compromises glucose-stimulated insulin secretion (GSIS) by mechanisms unknown to date. It has been speculated that some of these long-term effects are mediated by members of the peroxisome proliferator-activated receptor (PPAR) family via an induction of uncoupling protein-2 (UCP2). In this study we show that adenoviral coexpression of PPAR␣ and retinoid X receptor ␣ (RXR␣) in INS-1E ␤-cells synergistically and in a dose-and ligand-dependent manner increases the expression of known PPAR␣ target genes and enhances FA uptake and ␤-oxidation. In contrast, ectopic expression of PPAR␥/RXR␣ increases FA uptake and deposition as triacylglycerides. Although the expression of PPAR␣/RXR␣ leads to the induction of UCP2 mRNA and protein, this is not accompanied by reduced hyperpolarization of the mitochondrial membrane, indicating that under these conditions, increased UCP2 expression is insufficient for dissipation of the mitochondrial proton gradient. Importantly, whereas expression of PPAR␥/RXR␣ attenuates GSIS, the expression of PPAR␣/RXR␣ potentiates GSIS in rat islets and INS-1E cells without affecting the mitochondrial membrane potential. These results show a strong subtype specificity of the two PPAR subtypes ␣ and ␥ on lipid partitioning and insulin secretion when systematically compared in a ␤-cell context. (Endocrinology 146: 3266 -3276, 2005) P EROXISOME PROLIFERATOR-ACTIVATED receptors (PPARs) are members of the nuclear receptor superfamily and are activated by fatty acids (FAs) and FA derivatives. These transcription factors are central regulators of lipid homeostasis, and are involved in regulating insulin sensitivity and cellular growth and differentiation (1). All members of the PPAR family (PPAR␣, -␥, and -␦) bind to PPAR-responsive elements as heterodimers with retinoid X receptor (RXR), another member of the nuclear receptor superfamily (2). The different PPAR subtypes show very limited subtype specificity in transient transfections and in the in vitro binding to PPAR-responsive elements, but it is evident from a number of in vivo and ex vivo studies that the different PPAR subtypes do have specialized functions when acting on endogenous genes. Thus, PPAR␣ activates primarily genes encoding proteins involved in FA oxidation during fasting (3), whereas PPAR␥ activates genes directly involved in lipogenic pathways and insulin signaling (4). The different biological actions of PPAR subtypes are undoubtedly due in part to the differential expression patterns of the PPAR subtypes; however, there are also indications that the PPARs are biochemically different and behave differently when ectopically expressed in the same cell (5).
P EROXISOME PROLIFERATOR-ACTIVATED receptors (PPARs) are members of the nuclear receptor superfamily and are activated by fatty acids (FAs) and FA derivatives. These transcription factors are central regulators of lipid homeostasis, and are involved in regulating insulin sensitivity and cellular growth and differentiation (1) . All members of the PPAR family (PPAR␣, -␥, and -␦) bind to PPAR-responsive elements as heterodimers with retinoid X receptor (RXR), another member of the nuclear receptor superfamily (2) . The different PPAR subtypes show very limited subtype specificity in transient transfections and in the in vitro binding to PPAR-responsive elements, but it is evident from a number of in vivo and ex vivo studies that the different PPAR subtypes do have specialized functions when acting on endogenous genes. Thus, PPAR␣ activates primarily genes encoding proteins involved in FA oxidation during fasting (3), whereas PPAR␥ activates genes directly involved in lipogenic pathways and insulin signaling (4) . The different biological actions of PPAR subtypes are undoubtedly due in part to the differential expression patterns of the PPAR subtypes; however, there are also indications that the PPARs are biochemically different and behave differently when ectopically expressed in the same cell (5) .
All members of the PPAR family have been reported to be expressed in pancreatic ␤-cells (6); however, several recent reports challenge the current dogma on the functions of the different subtypes. It was recently shown that PPAR␣ ectopically expressed in INS-1 cells could induce lipid accumulation along with a modest increase in ␤-oxidation (7). Likewise, others deduce that PPAR␥ has lipooxidative potential promoting FA disposal in pancreatic ␤-cells (8) . This again disagrees with the conventional lipogenic role of PPAR␥, but is supported by reports indicating that PPAR␥ ligands induce delipidation of pancreatic islets (9, 10) . Thus, when related to findings in other tissues, the confusion about the direct function of PPAR subtypes in pancreatic ␤-cell lipid partitioning is remarkable.
FAs are known to have profound effect on the ability of ␤-cells to perform glucose-stimulated insulin secretion (GSIS) (1) . It is well established that FAs acutely potentiate insulin secretion by glucose and other secretagogues in a manner dependent on both chain length and degree of saturation (11, 12) . This effect is mediated by increased levels of intracellular long-chain FA-coenzyme A (FA-CoA) esters (13) as well as through direct activation of the G protein-coupled receptor 40 (14) . Because FA oxidation decreases cytoplasmic levels of long-chain acyl-CoA esters, conditions that increase FA oxidation have been suggested to counteract the potentiating effect of FAs on insulin secretion (15) .
In contrast to the acute effects of FAs on insulin secretion, exposure of ␤-cells to high levels of FAs over a longer time (Ͼ24 h) leads to elevated basal insulin secretion and compromised GSIS, a phenomenon termed lipotoxicity. The molecular mechanisms underlying lipotoxicity are unclear, but they have been suggested to involve modulation of the glucose flux (16, 17) , induction of uncoupling protein-2 (UCP2) (18, 19) , activation of UCP2 by increased levels of reactive oxygen species (ROS) (20, 21) , and facilitation of ceramide synthesis (22, 23) .
Particular attention has recently been given to the role of UCP2 in modulating GSIS. It is well established that UCP2 activity in ␤-cell mitochondria and GSIS capacity are negatively correlated in certain contexts (24, 25) , and evidence was recently presented that this uncoupling activity is dependent on the generation of ROS (26) . However, the physiological role of UCP2 in ␤-cells explaining the evolutionary conservation remains less evident from these studies. Other reports indicate that UCP2 may facilitate FA oxidation. It was found that ectopic expression of UCP2 in either the INS-1 insulinoma cell line or Zucker diabetic fatty (ZDF) rat islets significantly accelerated FA oxidation (27, 28) . This may be due to increased mitochondrial recycling of FAs (29, 30) or rapid neutralization of oxygen radicals (20, 31) . Interestingly, both PPAR␣ (7, 32) and PPAR␥ (33, 34) have been reported to induce UCP2 expression in ␤-cells and other cell types.
Hence, models positioning both PPAR␣ and -␥ as mediators of the adverse effects of FAs on ␤-cell function have been suggested (7, 34) . A significant reduction in GSIS by both ectopic PPAR␣ expression and the PPAR␣ agonist clofibrate led to the conclusion that PPAR␣ activity could indeed cause ␤-cell dysfunction, possibly through an induction of UCP2 (7) . However, these results are at odds with the generally protective and restorative effects of PPAR␣ activation in islets experiencing increased FA challenge (6, 35, 36) . A net contribution of PPAR␣ activation to ␤-cell dysfunction also disagrees with the glucolipotoxicity hypothesis describing the additive toxic effect of elevated levels of FAs and glucose on ␤-cell function as the ability of glucose to repress PPAR␣ expression and, accordingly, FA oxidation (37, 38) . Similarly, the finding that PPAR␥ agonists counteract FA toxicity on pancreatic ␤-cells (10, 36, 39) does not agree with PPAR␥ being the mediator of FA induction of UCP2 and attenuation of GSIS (34) The inconsistent observations on the effects of PPAR␣ and PPAR␥ on lipid partitioning and ␤-cell function prompted us to reinvestigate and directly compare the roles of these PPAR subtypes in ␤-cell function. In the present work we show that acute ectopic expression of PPAR␣ and RXR␣ synergistically and in a PPAR subtype-specific manner increases FA uptake and oxidation capacity and induces UCP2 expression in the INS-1E rat ␤-cell line. Interestingly, despite this increase in FA oxidation and UCP2 expression, transduction with PPAR␣/RXR␣ potentiates GSIS of both INS-1E cells and isolated rat islets. In contrast, acute ectopic expression of PPAR␥ and RXR␣ does not affect FA oxidation, but induces massive accumulation of triglycerides and impairs GSIS. These results confirm the roles of PPAR␣ as a catabolic and PPAR␥ as a lipogenic transcription factor also when ectopically expressed in pancreatic ␤-cells. Importantly, our results show that acute activation of PPAR␣ potentiates, whereas acute activation of PPAR␥ compromises, GSIS.
Materials and Methods

Cell culture
The cell line INS-1E was cultured as previously described (40) . The cells in use were all at passage numbers between 50 and 70 and were used for experiments at 70 -80% confluence. All media and supplements were obtained from Invitrogen Life Technologies, Inc. (Carlsbad, CA), and serum was purchased from HyClone (Logan, UT). Rat islets were isolated using collagenase digestion and cultured 24 h before experiments in RPMI 1640 supplemented as described (40) .
Adenovirus generation and transduction
Recombinant adenoviruses containing full-length mouse PPAR␣, PPAR␥2, and RXR␣ were generated using the AdEasy cloning system from Stratagene (La Jolla, CA). The three genes were initially cloned into pShuttle-CMV using SalI and EcoRV restriction sites and were moved to AdEasy-1 by homologous recombination. The linearized plasmids were transfected into 293-HEK cells, and the virus was amplified and purified using CsCl gradients. Viruses were initially titrated, and titers were estimated by a plaque assay-based approach. Subsequently, relative titers of functional viruses were equalized based on quantification of the adenoviral transcript AdE4 by real-time PCR. Relative titers 1, 2, 5, and 25 correspond to 4, 8, 20 , and 100 plaque-forming units/cell respectively.
After medium removal, cells were washed once in PBS and transduced for 90 min in RPMI 1640 supplemented as described above. Viruses were removed, and new medium containing specific agonists was added for an additional 24-or 48-h incubation. In all experiments, equal total amounts of AdVector were used as a control, and dimethylsulfoxide (DMSO) was added to the incubation medium. All experiments for RNA and protein extraction were performed in duplicate. 
RNA isolation and cDNA synthesis
Transduced INS-1E cells (relative titer, 1, 2, and 5; 24-h incubation) were harvested in guanidium thiocyanate, and RNA was isolated according to a modified Chomczynski-Sacchi protocol (42) . cDNA was prepared after deoxyribonuclease I treatment (Invitrogen Life Technologies, Inc.) by RT (Invitrogen Life Technologies, Inc., First-Strand Kit) of the isolated RNA primed by random hexamers (dexoy-NTP 6 ).
Real-time PCR
Quantitative three-step real-time PCR was performed on the ABI-7700 PRISM real-time PCR instrument (Applied Biosystems, Foster City, CA) using 2ϫ SYBR Green Master Mix (Sigma-Aldrich Corp.) and Sigma passive reference according to instructions from the manufacturer. PCRs were performed in duplicate. Primers for real-time PCR were designed using Primer Express 2.0 (Applied Biosystems), and specificity and efficacy were validated before use. All quantifications were performed with TFIIB as the internal standard and are presented as the fold increase over the control value.
Primer sequences (forward and reverse, respectively) are as follows: RXR␣, CCTGCCGAGACAACAAGGA and ACCGGTTCCGCTGTCT-CTT; PPAR␣, GTACCACTACGGAGTTCACGCAT and CGCCGAAA-GAAGCCCTTAC; PPAR␥, CACAATGCCATCAGGTTTGG and CAGCT-TCTCCTTCTCGGCCT; carnitine palmitoyl transferase-1a (CPT-1a), CTG-GTGGGCCACAAATTACG and AGGTAGATATATTCTTCCCACCAG-TCA; CPT-1b, TCCAAACATCACTGCCCAAG and GAATTGTGGCTG-GCACACTG; UCP2, CCTACAGCGCCAGATGAGCT and GAGTCGTA-GAGGCCAATGCG; medium-chain acyl-CoA dehydrogenase (MCAD), AGCTGCTAGTGGAGCACCAAG and TCGCCATTTCTGCGAGC; longchain acyl-CoA dehydrogenase (LCAD), TCACCAATCGTGAAGCT-CGA and CCAAAAAGAGGCTAATGCCATG; acyl-coenzyme A oxidase (ACO), CAGATAATTGGCACCTACGCC and AAGATGAGTTCCGTG-GCCC; fatty acid transport protein-1 (FATP1), GTGTACCCCATCCGTC-TGGT and CAGTGGCTCCATCGTGTCCT; FATP2, TGGACGCGATCA-TCTCTGG and TGTGGCGAAGGTTTCAAGGT; catalase, CGTGGGAA-ACAACACCCCTA and GGAAACAACATGGCATCCCT; perilipin, GGGACCTGTGAGTGCTTCCA and GTGGGCTTCTTTGGTGCTGT; pyruvate dehydrogenase kinase-4 (PDK4), CACGCTGGTCAAAGTT-CGAA and GCCATCGTAGGGACCACATT; CD36, TTCTGCTGCACG-AGGAGGA and AATGAGCCCACAGTTCCGAT; TFIIB, GTTCTGCTC-CAACCTTTGCCT and TGTGTAGCTGCCATCTGCACTT; and AdE4, CTCCGGAACCACCACAGAAA and GCAGACATGTTTGAGAGAAA-AATGG.
Mitochondrial membrane potential (⌬ m )
The ⌬ m of transduced INS-1E cells (relative titer, 5; 24-h incubation) was measured using the fluorescent probe, rhodamine 123 (Molecular Probes, Eugene, OR) as described previously (40) . Cells were maintained for 2 h in 2.5 mm glucose medium at 37 C before loading with 10 g/ml rhodamine 123 for 20 min at 37 C in Krebs ringer bicarbonate HEPES. The ⌬ m was monitored with excitation and emission filters set at 485 and 520 nm, respectively. Glucose (additions on top of basal, 2.5 mm), and then the protonophore carbonyl cyanide p-trifluoromethoxyphenylhydrazone was added to each well.
Insulin secretion
Insulin secretion from transduced INS-1E cells and rat islets (relative titer, 5; 24-h incubation) over a period of 30 min was measured by RIA using rat insulin as standard as previously described (40), and values were normalized to total insulin content.
Statistical analysis
Statistical evaluation of the data was performed using Student's twotailed t test on paired data. Data (fold increase over control value) are presented as the mean Ϯ sd (n Ն 3) or the mean Ϯ range (n ϭ 2).
Results
Synergy between adenovirally expressed PPAR␣ and RXR␣ in the INS-1E ␤-cell line
It is well documented that both pancreatic islets from rodents and ␤-cell-derived insulinoma cells express functional PPAR␣ (6, 37) . To investigate the acute effect of increased PPAR␣ activity on target gene expression in pancreatic ␤-cells, we transduced INS-1E cells with adenoviral vectors expressing PPAR␣. To investigate whether the endogenous level of RXR would become limiting for gene activation, we cotransduced with adenoviral vectors expressing RXR␣. INS-1E cells were transduced with the indicated viruses and cultured for 24 h with DMSO, the PPAR␣ agonist WY14643, and/or the RXR␣ agonist LG100268 as indicated. AdVector was used as a control. The viruses were all used with the relative titer 2 based on Ad4E expression (see Materials and Methods). Real-time PCR was used to quantify expression levels of the two classical PPAR␣ target genes, CPT-1b and ACO (Fig. 1) , which are rate-limiting for mitochondrial and peroxisomal FA oxidations, respectively. The expression of both genes was significantly induced by the specific agonists (P Ͻ 0.05-0.01) activating endogenous PPAR␣ and RXR, and this induction was further potentiated by ectopic expression of the nuclear receptors. Interestingly, coexpression of AdPPAR␣ and AdRXR␣ synergistically increased the expression of the target genes in both the absence and the presence of exogenous ligands. Transactivation of the two target genes by PPAR␣/RXR␣ in the absence of exogenous ligands indicates that either this transactivation is ligand independent, or significant levels of endogenous ligands are present in the INS-1E cells. However, the addition of receptor-specific, high affinity exogenous ligands potentiates the transaction of target genes by AdPPAR␣/AdRXR␣ to levels 5-and 6-fold above basal levels (P Ͻ 0.002). The synergy between AdPPAR␣ and AdRXR␣ reveals that the endogenous level of RXR␣ is not sufficient to fully support transcriptional activation by ectopically expressed PPAR␣, and that sequestration of RXR␣ from other nuclear receptors could be an undesirable side effect of overexpressing PPAR␣ alone. Thus, we chose to coexpress RXR␣ with PPAR␣ in subsequent experiments.
Dose-and subtype-dependent effects of adenovirally expressed PPAR␣ or PPAR␥ together with RXR␣ in INS-1E cells
To determine whether the effects on gene expression were specific for the PPAR␣ subtype, we transduced INS-1E cells with increasing titers of adenoviruses expressing either PPAR␣ or PPAR␥ in combination with AdRXR␣. To ensure comparable virus titers, we performed both plaque assays and routinely monitored the expression of the adenoviral E4 transcript (AdE4). After transduction, INS-1E cells were cultured 24 h with DMSO or the specific agonist, WY14643 or BRL49653, together with LG100268. Quantitative real-time PCR was used to quantify the ectopic expression levels of the PPARs and RXR␣ ( Fig. 2A) . Protein expression was determined by Western blotting (Fig. 2B) . At the level of both mRNA and protein, ectopically expressed PPAR␣ and PPAR␥ were equally abundant. Also, RXR␣ levels were comparable in the two sets of samples. Even very low doses of ectopically expressed PPAR␣ or PPAR␥ together with RXR␣ produced a significant and highly subtype-specific response at the level of target gene expression. The expressions of ACO and perilipin were dose-and subtype-dependently increased by AdPPAR␣ and AdPPAR␥ transduction, respectively (P Ͻ 0.05-0.02; Fig. 2C ). Only a modest effect of AdPPAR␥ was seen on ACO expression levels, whereas AdPPAR␣ had no effect on perilipin expression. Adenoviral expression of PPAR␥ is, therefore, a valuable control for PPAR␣-specific effects in INS-1E cells and vice versa.
FA uptake in INS-1E cells adenovirally transduced with PPAR␣ or PPAR␥ together with RXR␣
To study the metabolic effects of AdPPAR␣ and -␥ expression in ␤-cells, INS-1E cells were transduced with the indicated viruses using relative titers 1, 2, and 5 and were subsequently cultured 24 h with DMSO or the specific agonist, WY14643 or BRL49653, together with LG100268. Total RNA was isolated, and expression levels of the FA transporters CD36, FATP1, and FATP2 were quantified by realtime PCR (Fig. 3A) . Both AdPPAR␣ and AdPPAR␥ increased CD36 expression dramatically, whereas FATP1 expression was increased mainly by AdPPAR␣, and FATP2 was increased mainly by AdPPAR␥. FA uptake was measured by incubating the transduced cells with 14 C-labeled oleate and subsequently quantifying the 14 C content. In keeping with the increased expression of genes encoding FA transporters, both AdPPAR␣ and AdPPAR␥ increased FA uptake in the cells in a dose-dependent manner up to 2-fold (P Ͻ 0.05-0.001; Fig. 3B ).
Subtype-specific effects of adenovirally expressed PPAR␣ together with RXR␣ on FA oxidation genes in INS-1E cells
To investigate the impact of PPAR␣ on the metabolism of FAs taken up by the ␤-cell, the expression levels of genes associated with FA oxidation was determined (Figs. 4 and  2C) . All genes presented, PDK4, catalase, liver and muscle forms of CPT-1 (CPT-1a and -b), MCAD, LCAD, and ACO, were dose-dependently up-regulated by AdPPAR␣ (P Ͻ 0.05-0.001), whereas AdPPAR␥ only modestly affected expression levels. Thus, ectopic expression of PPAR␣/RXR␣ in INS-1E cells induces genes involved in both mitochondrial and peroxisomal FA oxidation in a PPAR subtype-specific manner. Neither the expression of cytochrome c nor that of nuclear respiratory factor-1 was affected by AdPPAR␣ (data not shown), indicating that mitochondrial biogenesis was not stimulated by PPAR␣ in this system.
FA and glucose oxidation in INS-1E cells adenovirally transduced with PPAR␣/RXR␣ or PPAR␥/RXR␣
With increased FA uptake and induction of key factors in FA oxidation, PPAR␣ would be expected to increase the FA oxidation capacity of the ␤-cell. To address this, INS-1E cells were transduced with the indicated viruses and respective ligands. Mitochondrial ␤-oxidation was determined in the presence or absence of etomoxir, an inhibitor of CPT-1 activity (Fig. 5A) . AdPPAR␣/AdRXR␣ dose-dependently increased oleate oxidation 4-to 12-fold (P Ͻ 0.05-0.02) in a manner completely blocked by etomoxir. In contrast, Ad-PPAR␥/AdRXR␣ had no effect on ␤-cell FA oxidation capacity, clearly demonstrating that increased ␤-oxidation is a PPAR␣-specific effect. Oleate oxidation was also increased 2-fold (P Ͻ 0.05) by activation of endogenous PPAR␣ with WY14643 ( Fig. 5B ) and was synergistically potentiated by concomitant RXR␣ activation (5-fold; P Ͻ 0.005). By contrast, glucose oxidation was unaffected by ectopic expression of either PPAR subtype together with RXR␣ (Fig. 5C ). , and CD36 were quantified by real-time PCR, normalized to TFIIB expression, and presented as the fold increase over the control (C) value. RNA was harvested in duplicate, and the range is indicated. B, [1- 14 C]Oleate uptake over 30 min was measured in triplicate, normalized to total cellular DNA, and presented as the fold increase over the control (C) value. The SD is indicated. Means significantly different from AdVector are indicated (*, P Ͻ 0.05; †, P Ͻ 0.02; ‡, P Ͻ 0.01; #, P Ͻ 0.005; §, P Ͻ 0.002; ʈ, P Ͻ 0.001). The results presented are representative for at least three independent experiments. . AdVector (C) was given, corresponding to a relative titer of 10 (or 50, protein). A and C, mRNA levels of AdPPAR␣, AdPPAR␥, and Ad-RXR␣ as well as endogenous ACO and perilipin were quantified by real-time PCR, normalized to TFIIB expression, and presented as the fold increase over the control (C) value. RNA was harvested in duplicate, and the range is indicated. B, Whole cell protein was extracted and separated by SDS-PAGE, and levels of AdPPAR, AdRXR␣, and TFIIB were determined by immunoblotting. *, P Ͻ 0.05; †, P Ͻ 0.02 (significantly different from AdVector). All results presented are representative of at least three independent experiments. subtypes specifically drive FAs taken up by the pancreatic ␤-cell along two opposite pathways, leading to FA oxidation and accumulation as neutral lipids, respectively.
Lipid accumulation in INS-
UCP2 levels and ⌬ m in INS-1E cells transduced with PPAR␣ or PPAR␥ together with RXRa
Previous studies have indicated a linkage between the UCP2 expression level and PPAR␣ activity. We therefore investigated whether ectopic expression of PPAR␣/RXR␣ would also increase UCP2 levels in this system. As shown in Fig. 7 , A and B, AdPPAR␣/AdRXR␣ markedly increased both the gene expression (P Ͻ 0.05-0.02) and the protein level of UCP2 in a receptor dose-dependent manner. Similar to other PPAR␣ target genes (Fig. 1) , UCP2 expression was significantly induced by exogenous ligands without ectopically expressed receptors and by coexpression of AdPPAR␣/ AdRXR␣ in the absence of exogenous ligands (data not shown). In contrast, transduction with AdPPAR␥/AdRXR␣ resulted in a lower and dose-independent induction of UCP2 expression. The induction of UCP2 by PPAR␣ was independent of FA oxidation, because etomoxir slightly potentiated, rather than blocked, the induction.
To investigate whether the PPAR␣/RXR␣-induced increase in FA oxidation capacity and/or the increased UCP2 levels would affect the basal mitochondrial potential or the glucose-induced hyperpolarization of the mitochondrial membrane, the ⌬ m was measured. INS-1E cells were transduced with AdPPAR␣/AdRXR␣ or AdVector at a relative titer of 5 and were incubated 24 h with DMSO or the specific agonists. Cells were subsequently loaded with rhodamine-123 and incubated at low glucose (2.5 mm) before stimulation with 15 mm glucose as indicated (Fig. 7C) . Despite increased UCP2 levels, AdPPAR␣/AdRXR␣ affected neither basal ⌬ m nor glucose-induced mitochondrial membrane hyperpolarization. In both the absence and the presence of ectopically expressed receptors, ligands slightly blunted the glucoseinduced mitochondrial membrane hyperpolarization. This effect may be ascribed to a direct, PPAR-independent effect on the mitochondrial membrane during the 24-h incubation as reported by others (21, 43) .
GSIS from INS-1E cells and rat islets adenovirally transduced with PPAR␣ or PPAR␥ together with RXR␣
The above results clearly demonstrate that ectopic Ad-PPAR␣/AdRXR␣ expression increases FA uptake and oxidation and results in up-regulation of UCP2 expression without affecting ⌬ m , whereas AdPPAR␥/AdRXR␣ expression results in FA uptake and lipid accumulation . To investigate the overall effect on ␤-cell GSIS, we transduced INS-1E cells with either AdPPAR/AdRXR␣ or AdVector and cultured 24 h with DMSO (control) or the respective agonists. Insulin secretion was measured over a 30-min period of stimulation. AdPPAR␣/AdRXR␣ significantly potentiated GSIS (ϩ54%; P Ͻ 0.02), whereas basal insulin secretion was unaffected (Fig. 8A) . In clear contrast, AdPPAR␥/AdRXR␣ markedly impaired GSIS (Ϫ65%; P Ͻ 0.01) implicating subtype-specific effects of PPAR␣ and PPAR␥ on GSIS (Fig. 8B) . Blocking FA oxidation with etomoxir did not compromise the potentiating effect of PPAR␣ (Fig. 8C) , suggesting that the potentiation of GSIS is caused by mechanisms other than increased ATP generation from FA oxidation. The cellular insulin content was not affected by the treatments (data not shown). In keeping with the effects of the ligands on ⌬ m (Fig. 7B) , the ligands caused a decrease in GSIS (data not shown), and ligands slightly decreased, rather than potentiated, the effect of PPAR␣/RXR␣ on GSIS (Fig. 8A) .
Finally, we wanted to investigate whether AdPPAR␣/ AdRXR␣ would also potentiate GSIS in primary ␤-cells. We therefore transduced isolated rat islets with AdPPAR␣/Ad-RXR␣ or AdVector and cultured for 24 h. As shown in Fig.  8D , AdPPAR␣/ AdRXR␣ specifically potentiated GSIS (ϩ48%; P Ͻ 0.005) in primary rat ␤-cells. In conclusion, ectopic expression of PPAR␣ together with its heterodimerization partner, RXR␣, potentiated GSIS from both clonal INS-1E ␤-cells and rat islets despite increased UCP2 levels and unaffected mitochondrial energy generation. In contrast, ectopic expression of PPAR␥ and RXR␣ significantly decreased GSIS. 
Discussion
The role of PPARs in ␤-cell physiology has been the focus of intense investigation. It is well known that all three PPAR subtypes are expressed in both islets and insulinoma cells, but their levels may vary considerably in response to other stimuli. A central role of PPAR␣ in leptin signaling and functional restoration of islets from diabetic ZDF rats was pointed out by Unger's group (6, 44) and later confirmed in a whole-body analysis comparing wild-type and PPAR␣-null animals (45) . The abnormal FA metabolism and defects in insulin secretion of ZDF rat islets could partly be ascribed to subnormal levels of PPAR␣. This linkage between PPAR␣ expression and normal ␤-cell function was also supported by studies of islets exposed to hyperglycemic conditions (37, 38) . In these studies it was shown that high glucose levels significantly repressed PPAR␣ expression and FA oxidation, and it was suggested that this effect of glucose would be central to the concept of glucolipotoxicity.
Also administration of PPAR␥ agonists has been reported to be beneficial for ␤-cell function under conditions with lipid excess. Both in human and murine islets, thiazolidinedione compounds known as potent PPAR␥ agonists have been shown to neutralize the adverse effects of FAs on ␤-cell function (10, 36, 39) . Whether these effect are mediated by PPAR␥ dependent mechanisms is currently not known. However, in other studies ectopic expression of PPAR␥ and acute administration of thiazolidinedione compounds to normal islets unexpectedly increased islet lipid oxidation and attenuated the GSIS (8) . Moreover, counteracting PPAR␥ function by chronic administration of a PPAR␥ antagonist totally attenuates FA induction of UCP2 and restored GSIS (34) , suggesting that PPAR␥ mediates, rather than protects against, FA toxicity within the time frame of investigation.
Recently, the beneficial physiological effects of PPAR␣ activity on islet cell function were questioned (7). Upon adenoviral transduction of INS-1 insulinoma cells with PPAR␣ or treatment with high doses of the hypolipidemic drug clofibric acid, a suppression of basal and glucose-stimulated insulin secretion was seen. This impairment of ␤-cell function was hypothesized to be caused by increased proton leakage from mitochondria due to elevated levels of UCP2, by depletion of cytosolic free FA pools due to increased FA oxidation, or by mitochondrial desensitization. Studies of islets isolated form PPAR␣ knockout mice are ambiguous. Some investigators reported an unaltered glucose response in PPAR␣ Ϫ/Ϫ islets (46), whereas others found that cultured islets from fasted PPAR␣ Ϫ/Ϫ mice hypersecrete insulin over a broad range of glucose concentrations compared with islets from wild-type mice (47) . The conflicting reports on the roles of PPAR␣ and -␥ in ␤-cells prompted us to reinvestigate the effects of these nuclear receptors on ␤-cells by acutely and ectopically expressing either of the PPAR subtypes in balance with their common heterodimerization partner RXR␣ in the highly differentiated rat ␤-cell line INS-1E and in rat islets. In experiments using more long-term or chronic activation (or deactivation) of the PPARs, it is difficult to distinguish between primary and secondary effects of the PPAR subtypes. By contrast, the strategy employed in this study, i.e. acute ectopic expression of the PPARs by adenoviral vectors, allowed us to determine the direct effects of elevated PPAR␣ or -␥ activity in pancreatic ␤-cells. In this first parallel analysis of the potencies of the PPAR␣ and -␥ subtypes, each subtype served as a valuable control for the specificity of the effects the other subtype. In addition, to determine whether endogenous PPARs play a role similar to that suggested by ectopic expression, we investigated the effects of acute treatment with PPAR ligands on ␤-cell gene expression and function.
The synergy between PPAR␣ and RXR␣ revealed that the endogenous level of RXR␣ is insufficient to fully support transcriptional activation by ectopically expressed PPAR␣. Sequestration of endogenous RXR␣ from its other dimerization partners could therefore be an undesirable side effect of overexpressing the PPARs alone. Thus, RXR␣ was coexpressed in subsequent experiments. We showed that coexpression of PPAR␣ and RXR␣ led to significant induction of target gene expression even in the absence of exogenous ligands. This finding indicates that either considerable amounts of endogenous ligands are present in INS-1E cells or these receptors are able to activate endogenous target genes in the absence of ligands.
We found that both PPAR␣ and PPAR␥ dose-dependently increased the FA uptake of INS-1E cells. However, the two PPARs directed the incoming FAs along different metabolic pathways. Whereas both activation of the endogenous PPAR␣ and ectopically expressed PPAR␣ induced ␤-oxidation of the FAs, ectopic expression of PPAR␥ facilitated lipid accumulation in the ␤-cell. This subtype specificity in lipid partitioning was reflected in the strict subtype-specific induction of target genes, which is conserved even when the PPARs are ectopically expressed. This finding is important for the interpretation of our data, because it indicates that the specific effects elicited by the ectopically expressed PPARs to a very large extent reflect the potencies of endogenous PPARs. A change in the relative levels of the PPAR subtypes thus is acutely translated into different metabolic profiles of the ␤-cell. Under normal physiological conditions, ␤-cell expression of PPAR␣ exceeds that of PPAR␥ (6, 38) . This is in line with our present findings that endogenous PPAR␣ levels are sufficient to stimulate target gene expression and FA oxidation, whereas agonist activation of the endogenous PPAR␥ affects neither target genes (results not shown) nor lipid accumulation (Fig. 6) . It can be speculated that under hyperglycemic or hyperlipidemic conditions, the picture would change, mimicked by PPAR␥ overexpression, and lipid accumulation would be facilitated. . A, UCP2 mRNA was quantified by real-time PCR, normalized to TFIIB expression, and presented as the fold increase over the control (C) value. RNA was harvested in duplicate, and the range is indicated. B, Whole cell protein was extracted and separated by SDS-PAGE, and levels of UCP2 and TFIIB were estimated by immunoblotting and determined by densiometric scanning. C, ⌬ m was measured using rhodamine 123. Where indicated, glucose was increased to 15 mM. Means significantly different from AdVector are indicated (*, P Ͻ 0.05; †, P Ͻ 0.02). All results presented are representative of at least three independent experiments.
In agreement with previous reports (7, 32) , PPAR␣ induced UCP2 expression. This increase was a direct effect of PPAR␣, rather than secondary to the increased FA oxidation, and was also reflected in increased UCP2 protein levels. Interestingly, neither basal ⌬ m nor glucose-induced mitochondrial hyperpolarization was affected by increased PPAR␣ activity and the resulting UCP2 induction. Thus, the moderate induction of UCP2 per se appeared not to uncouple the mitochondrial membrane. On the contrary, ligands of PPAR␣, PPAR␥, and RXR␣ partially compromised the glucose-induced hyperpolarization of the mitochondrial membrane in a receptor-independent manner. This observation is probably due to the effects of these lipophilic compounds on mitochondrial respiratory chain function, as has been reported by others (21, 43) .
Importantly, GSIS was significantly potentiated by PPAR␣/RXR␣ expression in both INS-1E cells and rat islets despite the ability of PPAR␣/RXR␣ to increase UCP2 levels. PPAR␥/RXR␣, in contrast, only increased UCP2 mRNA levels 1.5-to 2-fold, but severely reduced both basal insulin secretion and GSIS by approximately 55%. To understand the discrepancy between UCP2 induction and effects on insulin secretion, the activity of UCP2 should be considered. In recent reports, superoxide was pointed out as the endogenous activator of UCP2 uncoupling activity (21, 26) in a potentially protective feedback loop. It is also well known that ROS production is induced not only by mitochondrial oxidation processes through reduction of respiratory complex I (21), but also by complex lipids, such as ceramide, in various cell types (48 -50) . In ␤-cells, ceramide generation is part of the lipotoxic/cytotoxic effect associated with exposure to saturated FAs and deposition of these rather than oxidation (22, (51) (52) (53) . Thus, PPAR␥ expression might increase ROS production through increased lipid uptake in cells not metabolically adjusted to handle this challenge. In contrast, PPAR␣ turns on a complete program of lipid uptake, lipid oxidation, neutralization of ROS, and adaptation of the citric acid cycle. This potentially equilibrates the FA flux at a higher level without increasing ROS generation or compromising the discrete compliant pools of FAs in the cytoplasm predicted to contribute to the full insulin response (13, 54, 55) .
Another important aspect in understanding the observed differences between the two PPAR subtypes on GSIS may be the PPAR␣-stimulated PDK4 expression and expected augmented anaplerotic flow into the citric acid cycle. Anaplerosis is critical to the insulin response, and inhibition of pyruvate dehydrogenase by PDK4 could sensitize the ␤-cell to glucose (56, 57) , potentially through increased formation of mitochondrial coupling factors (58, 59) . Such a mechanism would be in agreement with the observed potentiation of GSIS in this study and our finding that elimination of the ATP contribution from FA oxidation during GSIS did not interfere with the positive effect of PPAR␣. In a recent review, Sugden and Holness (60) proposed a concept, for PPAR␣ action on insulin secretion, also consistent with our present observations. Hence, increased PPAR␣ activity could play a role in liporegulation through improved ␤-cell function and compensatory insulin secretion in the hyperlipidemic state in vivo. The recent suggestion that PPAR␣ activation by FAs is responsible for ␤-cell adaptation to fasting conditions by reducing the pool of cytoplasmatic acyl-CoA esters critical for GSIS (47) is an interesting proposal and does not directly conflict with the present gain of function data. Our results show that acute activation of PPAR␣ has a net potentiating effect on GSIS, but do not exclude that PPAR␣ under some conditions could promote exhaustion of the cytoplasmic acyl-CoA pool and blunt GSIS. However, under our conditions this is either not rate limiting or is counteracted by other positive effects of PPAR␣.
The finding that acute ectopic expression of PPAR␥ causes massive triglyceride accumulation in INS-1E cells is in keeping with the current view that PPAR␥ is a lipogenic transcription factor. However, this observation is at odds with the findings of Parton et al. (8) , who showed that ectopic expression of PPAR␥ increases FA oxidation and decreases lipid accumulation in rat islets. It is possible that these discrepancies are due to differences in ectopic expression levels, the duration of the experiment (24 vs. 48 h), or the fact that Parton et al. (8) ectopically expressed PPAR␥1, whereas we expressed PPAR␥2. However, to date, significant functional differences between PPAR␥ isoforms ␥1 and ␥2 have not been described. In our system, glucose oxidation was not significantly affected, and it appears more likely that the PPAR␥-induced attenuation of GSIS is due to the massive lipid accumulation and increased ceramide synthesis reported to result from such accumulation. However, in the chronic hyperlipidemic state, PPAR␥ could be important for compensatory ␤-cell hyperplasia, as suggested by islet studies of ␤-cell-specific PPAR␥ knockout mice (61) .
In conclusion, a significant subtype specificity is observed when comparing PPAR␣ and PPAR␥ in pancreatic ␤-cells. Acute ectopic expression of PPAR␣/RXR␣ increases the FA oxidation capacity in INS-1E cells and results in a net potentiation of GSIS in both INS-1E cells and primary rat islets. The increased expression of UCP2 protein does not per se ablate glucose-stimulated hyperpolarization of the mitochondrial membrane, an observation in agreement with the idea that uncoupling by UCP2 requires activation by reactive oxygen species. The exact molecular mechanisms underlying the potentiation of GSIS by PPAR␣ are unclear at this point, but may involve enhanced anaplerotic feeding of the citric acid cycle and generation of mitochondrial coupling factors. This would be in keeping with the activation of PDK4 expression by PPAR␣ and the observation that the potentiation of GSIS is not dependent on ongoing FA oxidation or accompanied by an increase in ⌬ m . In contrast, acute ectopic expression of PPAR␥/RXR␣ increases triglyceride accumulation and leads to attenuation of GSIS. Of note, agonist activation of endogenous PPAR␣, but not PPAR␥, affects gene expression and lipid metabolism similarly to ectopic expression of the nuclear receptor. Hence, under the present normoglycemic and normolipidemic conditions, PPAR␣ appears to be the functionally more important subtype.
